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in all-cause mortality from walking and cycling
and shape of dose response relationship
Paul Kelly1,2*, Sonja Kahlmeier3, Thomas Götschi3, Nicola Orsini4, Justin Richards5, Nia Roberts6,
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Abstract
Background and objective: Walking and cycling have shown beneficial effects on population risk of all-cause
mortality (ACM). This paper aims to review the evidence and quantify these effects, adjusted for other physical
activity (PA).
Data sources: We conducted a systematic review to identify relevant studies. Searches were conducted in
November 2013 using the following health databases of publications: Embase (OvidSP); Medline (OvidSP); Web of
Knowledge; CINAHL; SCOPUS; SPORTDiscus. We also searched reference lists of relevant texts and reviews.
Study eligibility criteria and participants: Eligible studies were prospective cohort design and reporting
walking or cycling exposure and mortality as an outcome. Only cohorts of individuals healthy at baseline were
considered eligible.
Study appraisal and synthesis methods: Extracted data included study population and location, sample size,
population characteristics (age and sex), follow-up in years, walking or cycling exposure, mortality outcome, and
adjustment for other co-variables. We used random-effects meta-analyses to investigate the beneficial effects of
regular walking and cycling.
Results: Walking (18 results from 14 studies) and cycling (8 results from 7 studies) were shown to reduce the risk
of all-cause mortality, adjusted for other PA. For a standardised dose of 11.25 MET.hours per week (or 675 MET.
minutes per week), the reduction in risk for ACM was 11% (95% CI = 4 to 17%) for walking and 10% (95% CI = 6 to
13%) for cycling. The estimates for walking are based on 280,000 participants and 2.6 million person-years and for
cycling they are based on 187,000 individuals and 2.1 million person-years. The shape of the dose–response
relationship was modelled through meta-analysis of pooled relative risks within three exposure intervals. The
dose–response analysis showed that walking or cycling had the greatest effect on risk for ACM in the first (lowest)
exposure interval.
Conclusions and implications: The analysis shows that walking and cycling have population-level health benefits
even after adjustment for other PA. Public health approaches would have the biggest impact if they are able to increase
walking and cycling levels in the groups that have the lowest levels of these activities.
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Background
Regular walking and cycling have become a key focus
of physical activity (PA) promotion [1]. However, the
expected public health benefit for different exposure levels
on all-cause mortality (ACM) remains unclear. Most stud-
ies on PA and ACM have focussed on overall or leisure-
time PA [2,3], and there have been relatively fewer studies
reporting walking or cycling as the exposure [4]. Fewer
still have reported the independent effect of walking or
cycling, meaning results may be confounded by other PA.
It may be that groups with high levels of walking or
cycling do more leisure time or occupational PA which
would inflate the health benefits attributed to these
behaviours.
For public health policy, health impact assessment,
comparative risk assessment, and health economic
modelling, better evidence is required to address two
questions: (1) what is the reduced risk for ACM from
achieving PA recommendations through walking or
cycling (adjusted for other PA); and (2) what is the
shape of the dose–response curve across the range of
exposures for walking and cycling?
When considering ACM and walking, previous meta-
analyses have suggested a reduced risk of between 3
and 32% [2,3,5]. This wide range is likely a function of
non-standardised approaches to quantifying the exposure
of walking and inclusion of studies that did not adjust for
other PA. There has not previously been a meta-analysis
of cycling and ACM, as sufficient evidence is only recently
available [4].
Our first aim is to estimate the reduction of risk for
ACM from walking and cycling using a robust method
that would be of use to health modelling and risk assess-
ment. We will standardise the exposures of walking and
cycling in line with international PA recommendations
and will only consider studies that adjusted for other PA.
This will be of use to health modelling relying on basic
walking and cycling data. In terms of the dose–response
curve, it is increasingly accepted that the relationship
between PA and health benefits may not be linear [3,4,6].
That is, a 30 minute per week increase in walking or
cycling might result in benefits of differential magnitude if
the existing baseline levels were, for example, 0 compared
to 90 minutes per week. This is important for modelling
change in behaviour as populations will not all have zero
walking or cycling at baseline, and uptake is not always
equitable [7]. Therefore, our second aim is to characterise
the shape of the dose response relationships for walking
and cycling across the range of exposures. This will be
of use to health modelling efforts that have access to
informative baseline, before and after, and differential
uptake data.
Research question 1
What is the reduced risk of all-cause mortality from an
exposure of (i) walking and (ii) cycling equivalent to
physical activity recommendations (11.25 MET.hours
per week)? (Population: identified cohort participants,
healthy at baseline; Intervention: exposure to regular
walking or cycling above referent level; Comparison:
exposure to regular walking or cycling at referent (lowest)
level; Outcome: all-cause mortality during follow up
(controlled for other PA); Study design: prospective
cohort studies).
Research question 2
What is the shape of the dose–response relationship for
reduction in risk of all-cause mortality across the reported
ranges of (i) walking and (ii) cycling exposures?
Methods
Systematic review
Selection criteria
The inclusion criteria for studies were as follows: pro-
spective cohort design; healthy population at baseline
(patient cohorts were excluded); exposure of regular
walking or cycling at baseline was reported (and quantified
by duration, distance or frequency); all-cause mortality
rates, relative risks, or hazard ratios were reported (and
adjusted for other physical activity). Only studies in
English language were considered eligible.
Search strategy
We identified included studies in a 6 stage process.
Searches were conducted in November 2013 using the
following health databases of publications (Stage 1):
Embase (OvidSP) (1974 – present); Medline (OvidSP)
(1948-present); Web of Knowledge (1945 – present);
CINAHL; SCOPUS; SPORTDiscus. The full search
details (including search terms), identification, and data
extraction strategy are available in the PROSPERO
record (see Study protocol below). We also searched the
reference lists of included studies and other topic-
related systematic reviews [2-5,8] and contacted authors
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of all eligible studies for known grey literature and studies
not published in peer-reviewed journals (Stage 2). One
identified study originated from a book chapter and the
lead author provided further details by email for data ex-
traction that were not otherwise available. All records were
assessed by two independent reviewers (PK and CF) at first
and second appraisal (Stage 3 and 4) and any disagreements
were resolved by discussion and mutual agreement. A third
external researcher assessed 15% of excluded records at
Stage 3 (contribution reported in acknowledgements).
Detailed evaluation of full texts (Stage 5) was conducted
independently (PK and CF) with disagreements resolved by
discussion with a third reviewer (SK). It was confirmed
through author contact that studies from the same cohorts
in conducted analysis on different subsets of individuals
and therefore eligible for inclusion (Stage 6).
Data extraction
We collected data on study population, cohort name,
study location, sample size, population characteristics
(age and sex), follow-up (years and percentage), walking
or cycling measures and reported exposures, outcome
measures, other PA measures, reported outcomes (events,
group size, relative risks or hazard ratios), and adjustment
for other co-variables. Data extraction was performed
by one researcher (PK). 25% of extracted data were
cross-checked by an external researcher (contribution
reported in acknowledgements).
Quality assessment
Study quality was assessed using a Newcastle Ottawa Scale
(NOS) for Cohort Studies with appropriate selections
made for primary controlling variable and length of follow
up [9]. Two assessors (PK and JR) independently graded
each study, and disagreements were resolved by discussion
and mutual agreement. The NOS assessed: 1) represen-
tativeness of cohort, 2) selection of non-exposed cohort,
3) ascertainment of exposure, 4) demonstration that
co-morbidities were not present at start of study, 5)
control for main variable (age), 6) controls for any
additional factors, 7) how outcome was ascertained, 8)
follow-up time sufficient for outcome (5 years), and 9) per-
centage follow-up adequate. A study could score one point
in each category with a possible total of nine points.
Meta-analysis
Standardization of exposures
The reported exposure levels of walking and cycling
were converted into the same metric in order to stand-
ardise the magnitude of the exposures and calculate the
associated risk reduction. We chose MET.hours per
week for this metric as this allowed us to consider both
the duration and the intensity of the reported exposures.
We adopted a conservative approach to convert the
exposures into the common metric. For conversions,
walking was defined to be 4.0 METs if not stated. This level
was taken from the Compendium of Physical Activities
(Taylor Code 015) and is described as “walking to work
or class” [10]. Cycling was defined to be 6.8 METs if not
stated. This level is described as “to/from work, self-
selected pace” in the Compendium of Physical Activities
[10]. These selections were based on the assumption that
walking and cycling at a population level would be pre-
dominantly utilitarian i.e. active travel. The sensitivity of
selecting different plausible values for walking and cycling
was tested. If the exposure was reported as distance we
assumed a walking speed of 3.3 mph (or 5.3 km/h) to
represent 4.0 METs [10] for conversions. If exposure was
reported as sessions per week we assumed a session lasted
30 minutes, a method previously used by Woodcock
et al. [3]. If exposures were reported as a range (e.g. 0 to
30 minutes per day) we took the midpoint of the range.
If categories were open ended (e.g. more than 60 -
minutes per day) we assumed the range was the same
width as the preceding range and estimated the mid-
point accordingly.
Calculating point estimates at 11.25 MET.hours per week
Before constructing Forest plots, for each study we
calculated point estimates of risk reduction at an
exposure of walking or cycling equivalent to inter-
national PA recommendations. Current global recom-
mendations for adults’ PA are 150 minutes (2.5 hours)
of moderate-intensity aerobic PA per week [11]; these
recommendations define moderate intensity as 3 to 6
METs (metabolic equivalents) [11]. Taking the mid-
point at 4.5 METs, we converted the recommendations
to 11.25 MET.hours per week (the same metric as our
converted exposures).
For each study we plotted reported risks against
converted exposures and calculated the risk-estimate
at 11.25 MET.hours per week. When referent categories
were non-zero, we plotted additional MET.hours per week
above baseline such that a relative risk of 1.0 equated to
zero additional walking or cycling. For these calculations
we assumed a linear relationship between walking and
cycling and ACM risk. We also calculated point-estimates
for other dose–response relationships by transforming the
exposures of walking and cycling. Specifically, we tested
the log and other various power transformations (0.75,
0.50, 0.375, 0.25) which have been theorised to represent
the dose–response relationship between PA and ACM [3].
The confidence intervals for the point estimate at
11.25 MET.hours per week were calculated as the
weighted mean of the standard errors for each of the
exposure groups, extracted from the confidence inter-
vals on reported relative risks.
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Forest plots and funnel plots
The pooled relative risks corresponding to 11.25 MET.
hours per week were then estimated using random-
effects meta-analysis. This selection was made as
included studies met the criteria for this approach [12].
Using the point estimates for risk reduction, random
effects meta-analyses were performed using Stata ver-
sion12 (StataCorp LP, College Station, Texas, USA) for
walking and cycling. Variance in results that may be due
to heterogeneity between studies was assessed using the
I2 statistic. These data were displayed on Forest plots.
Funnel plots were analysed to assess the possibility of
small-study or publication bias.
Dose–response relationship
We chose to investigate the dose–response relationship
through meta-analysis of pooled relative risks within
three exposure intervals. A similar approach has been
previously demonstrated for all PA and mortality [13].
Selection of the interval ranges (exposure categories)
was based on the distribution of the reported walking
and cycling exposures to give sufficient results in each
category to allow meta-analysis. For walking, the cat-
egories for exposures in MET.hours per week were [1 to
16], [16 to 30] and [30 to 70]. For cycling the categories
were [1 to 24], [24 to 40] and [40 to 90].
We then conducted separate random effects meta-
analyses for each category using the risk reductions for ex-
posures within the category range. When there was more
than one exposure group from the same study within a sin-
gle category we pooled the RR using the method proposed
by Hamling et al. [14]. This method requires group size and
number of events for each category. Included study authors
were contacted by email to request missing data; studies
were excluded from this analysis when these data were not
available. When assessing the dose response relationship
we were able to include results from 11/14 walking studies
(79%) and 6/7 cycling studies (86%).
From these results we calculated the incremental
change in risk for each MET.hour per week increase in
either walking or cycling for the different regions of the
exposure range. Finally the results of the separate
meta-analyses were plotted against the midpoint of
the respective exposure category. Confidence intervals
were also plotted for each data point.
The analyses approaches are summarised in the ana-
lysis flow chart (Additional file 1: Figure S1).
Study protocol
The full study protocol was registered with PROSPERO
(International database of prospectively registered system-
atic reviews in health and social care) and is available at
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?
ID=CRD42013004266.
Ethical approval
Ethical approval was not required for this secondary
analysis of cohort studies.
Results
Systematic review
A total of 8,901 titles were identified from databases,
and 427 were retained after first appraisal with 4 further
records identified from other sources. After second ap-
praisal 49 full texts were retained for detailed evaluation
with 18 meeting all inclusion criteria.
A number of identified walking studies were excluded
from analysis after detailed evaluation: 18 did not adjust
or control for other PA, 3 did not present ACM risk
reductions (e.g. reported survival function), 3 did not
report “walking only” on closer inspection (e.g. exposure
was walking and standing), 3 reported walking by pace only
preventing assessment of dose and 3 analysed the same
participants as an already included higher quality study. We
also excluded a number of studies that used walking as a
dimension of PA (e.g. Low = no PA, Medium=Walking at
least 3 hours per week, High = Sports and exercise for
3 hours per week) as these did not allow assessment of the
adjusted effect of walking. One small cycling study in older
adults from the Netherlands matched the criteria for
cycling and mortality, but was excluded as it did not control
for other PA [15].
From the 18 included studies, 14 studies presented a
total of 18 results on walking and ACM, and 7 studies
presented a total of 8 results on cycling and ACM. These
data are displayed in the study flow chart (Figure 1).
Additional file 2: Table S1 shows the full data extraction
for all included studies. Additional file 3: Table S2 shows
the NOS quality scores.
Description of studies
Walking studies
Of the 14 included studies, 7 came from Western Europe
[16-21], 4 from the USA [22-25], 2 from China [26,27]
and 1 from Japan [28]. The majority of results showed a
reduced risk of ACM from walking, though only 5 from
18 (28%) were statistically significant. The included studies
contained 280000 individuals and 2.6 million person years.
The aggregated mean age for participants was 56.6 years
(range 20–93 years). The studies were generally high
quality: 4 scored 9/9, 6 scored 8/9 and 4 scored 7/9 on
the NOS.
Cycling studies
The majority of studies (6 of 7) came from Western Europe
[16,29-33] (4 of which were from Denmark, 1 from UK and
1 from Germany), and 1 study came from China [27].
Cycling to work was the most common cycling domain
assessed. Six studies showed either a statistically significant
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or a non-significant but still beneficial association be-
tween cycling and ACM. One study showed a small
non-significant non-beneficial association between cycling
and ACM [32].
The 7 studies for cycling contained 187000 individuals
and 2.1 million person-years. The aggregated mean age
for participants was 56.6 years (range 20–93 years)
which was the same as the walking mean age and range.
The studies were generally high quality: 2 scored 9/9, 2
scored 8/9, 2 scored 7/9 and 1 scored 6/9.
Exposure conversions and point estimates
Table 1 shows the included studies with the reported
exposure categories and risk reductions. It also shows
the conversion of reported exposure categories to MET.
hours per week and derived point estimates for risk
reduction at 11.25 MET.hours per week (with extracted
95% CIs).
Once converted to point estimates at an exposure of
11.25 MET.hours per week, 3 of the 18 walking results
(17%) were statistically significant based on our extracted
confidence intervals. For cycling, 4 of the 8 results (50%)
were significant at 11.25 MET.hours per week. There were
no obvious patterns or differences between the results that
were statistically significant and non-significant in terms
of mean age, follow-up length, exposure ranges or study
quality.
Meta-analysis
Random effects meta-analysis of the point estimates for
the 18 results from 14 walking studies found a reduced
risk of 0.89 (95% CI = 0.83 to 0.96) corresponding to an
exposure of 11.25 MET.hours per week (Figure 2).
Random effects meta-analysis of point estimates for the
8 results from 7 cycling studies found a risk-reduction
of 0.90 (95% CI = 0.87-0.94) corresponding to an ex-
posure to 11.25 MET.hours per week (Figure 3).
Sensitivity analyses on the selection of intensity for
conversion of walking and cycling exposures were
carried out and the calculations were found to be
robust. For example, conducting the meta-analyses
using an average intensity of 3.0 METs (instead of 4.0
Figure 1 Flow chart for study selection.
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Table 1 Reported risks and calculated point estimates at 11.25 MET. hours per week by study
Study - result Reported exposure category Conversion to MET.
hours per week
Additional MET.
hours per week
Reported risk 95% confidence
interval
Point estimate at 11.25 MET. hours
per week (extracted 95% CI)
Walking
Johnsen (2013) [16] - Men Non-active 0 0 1 - -
Active = 3 hours/week 12 12 1.01 0.91 to 1.13 1.01 (0.91 to 1.12)
Johnsen (2013) [16] - Women Non-active 0 0 1 - -
Active = 3 hours/week 12 12 0.92 0.80 to 1.06 0.93 (0.80 to 1.07)
Wang (2013) [26] None 0 0 1 - -
5-6 hours/week @ 3.3 METs 18.15 18.15 0.84 0.73 to 0.96 0.90 (0.79 to 1.03)
Sabia (2012) [17] <3.5 hours/week 0 0 1 - -
3.5-5.9 hours/week 12 12 0.83 0.63 to 1.08 -
6+ hours/week 22 22 0.81 0.61 to 1.07 0.89 (0.73 to 1.08)
Nagai (2011) [28] - Men <1 hour/day 14 0 1 - -
>1 hour/day 42 28 0.9 0.82 to 0.98 0.96 (0.88 to 1.05)
Nagai (2011) [28] - Women <1 hour/day 14 0 1 - -
>1 hour/day 42 28 0.95 0.82 to 1.10 0.98 (0.85 to 1.14)
Stamatakis (2009) [18] - Men None 0 0 1 - -
Med (2 sessions/week) 4 4 1.1 0.86 to 1.14 -
High (7 sessions/week) 14 14 0.91 0.73 to 1.13 0.95 (0.84 to 1.08)
Stamatakis (2009) [18] - Women None 0 0 1 - -
Med (2 sessions/week) 4 4 0.89 0.69 to 1.14 -
High (7 sessions/week) 14 14 0.92 0.72 to 1.18 0.92 (0.77 to 1.09)
Besson (2008) [32] Non walker 0 0 1 - -
Walk 0–90 min/week 3 3 0.96 0.80 to 1.15 -
Walk 90 min+/week 9 9 0.89 0.73 to 1.09 0.86 (0.78 to 0.95)
Matthews (2007) [27] 0-3.4 MET.hours/day 11.9 0 1 - -
3.5-7 MET.hours/day 36.75 24.85 0.94 0.89 to 1.09 -
7.1-10 MET.hours/day 59.5 47.6 0.83 0.69 to 1.00 -
10+ MET.hours/day 81.2 69.3 0.86 0.71 to 1.05 0.97 (0.88 to 1.08)
Schnohr (2007) [19] – Men <0.5 hours/day 7 0 1 - -
0.5-1.0 hours/day 21 14 0.87 0.68 to 1.10 -
1.0-2.0 hours/day 42 35 0.95 0.75 to 1.21 -
2.0+ hours/day 70 63 0.89 0.69 to 1.14 0.98 (0.85 to 1.13)
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Table 1 Reported risks and calculated point estimates at 11.25 MET. hours per week by study (Continued)
Schnohr (2007) [19] - Women <0.5 hours/day 7 0 1 - -
0.5-1.0 hours/day 21 14 1.00 0.77 to 1.30 -
1.0-2.0 hours/day 42 35 1.04 0.80 to 1.36 -
2.0+ hours/day 70 63 0.8 0.59 to 1.10 0.98 (0.83 to 1.15)
Smith (2007) [22] None 0 0 1 - -
<1 mile/day 4.3 4.3 0.98 0.76 to 1.25 -
>1 mile/day 12.9 12.9 0.89 0.67 to 1.18 0.91 (0.75 to 1.10)
Lee (2000) [23] <5 km/week 1.9 0 1 - -
5 to 10 km/week 5.8 3.9 0.91 0.82 to 1.02 -
10 to 20 km/week 11.5 9.6 0.92 0.83 to 1.01 -
>20 km/week 19.2 17.3 0.84 0.75 to 0.94 0.89 (0.84 to 0.95)
Bath (1998) [20] Less than 10 minutes/day 2.3 0 1 - -
More than 10 minutes/day 7 4.7 0.75 0.63 to 0.82 0.40 (0.34 to 0.48)
Hakim (1998) [24] Less than 0.5 hour 4.7 0 1 - -
0.5-1.0 hour 14 9.3 0.66 0.47 to 0.91 -
More than 1 hour 46.7 42 0.55 0.37 to 0.83 0.87 (0.67 to 1.12)
Wannamethee (1998) [21] 0 min/day 0 0 1 - -
0-20 min/day 4.7 4.7 1.15 0.73 to 1.79 -
21-40 min/day 14 14 1.06 0.75 to 1.50 -
41-60 min/day 23.3 23.3 0.97 0.65 to 1.46 -
60+ min/day 32.7 32.7 0.62 0.37 to 1.05 0.93 (0.75 to 1.15)
La Croix (1996) [25] Less than 1 hour/week 2 0 1 - -
1-4 hours/wee 10 8 0.83 0.53 to 1.29 -
More than 4 hours/week 22 20 0.91 0.58 to 1.42 0.92 (0.67 to 1.27)
Cycling
Johnsen (2013) [16] - Men Non-active 0 0 1 - -
Active = 2 hours/week 13.6 13.6 0.79 0.73 to 0.85 0.93 (0.87 to 0.99)
Johnsen (2013) [16] - Women Non-active 0 0 1 - -
Active = 2 hours/week 13.6 13.6 0.91 0.85 to 0.97 0.83 (0.77 to 0.89)
Sahlqvist (2013) [29] 0 min/week 0 0 1 - -
1-59 min/week 3.4 3.4 0.96 0.78 to 1.17 -
60+ min/week 10.2 10.2 0.91 0.84 to 0.99 0.90 (0.87 to 0.94)
Andersen (2011) [30] 0 0 0 1 - -
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Table 1 Reported risks and calculated point estimates at 11.25 MET. hours per week by study (Continued)
0-3 hours/week 10.2 10.2 0.78 0.69 to 0.88 -
3-7 hours/week 24 34 0.76 0.68 to 0.85 -
7+ hours/week 61.2 61.2 0.7 0.62 to 0.78 0.94 (0.88 to 1.00)
Schnohr (2010) [31] 15 min slow 7 0 1 - -
15 min ave 11.9 4.9 0.67 0.49 to 0.92 -
15 min fast 17.5 10.5 0.54 0.31 to 0.94 -
45 min slow 21 14 0.87 0.57 to 1.33 -
45 min ave 35.7 28.7 0.7 0.51 to 0.95 -
45 min fast 52.5 45.5 0.44 0.28 to 0.69 -
75 min slow 35 28 0.85 0.53 to 1.35 -
75 min ave 59.5 52.5 0.71 0.52 to 0.57 -
75 min fast 87.5 80.5 0.68 0.46 to 1.01 0.93 (0.80 to 1.07)
Besson (2008) [32] Non cyclist 0 0 1 - -
0-30 min/week 1.7 1.7 1.02 0.77 to 1.35 -
30 +min/week 5.7 5.7 1.01 0.76 to 1.36 1.03 (0.84 to 1.26)
Matthews (2007) [27] 0 MET.hours/day 0 0 1 - -
0.1-3.4 MET.hours/day 12.3 12.3 0.79 0.61 to 1.01 -
3.5+ MET.hours/day 36.1 36.1 0.66 0.40 to 1.07 0.88 (0.68 to 1.15)
Andersen (2000) [33] No biking to work 0 0 1 - -
Bike to work 3 hours/week 20.4 20.4 0.72 0.57 to 0.91 0.85 (0.67 to 1.07)
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METs) for walking or 8.0 METs (instead of 6.8 METs)
for cycling for the conversions made a 1 percentage
point difference to the final meta-analyses results.
Likewise, when deriving point estimates of risk we tested
various transformations to the exposure of walking and
cycling to simulate non-linear dose–response relation-
ships. Specifically we tested log-linear and various power
transformations (0.75, 0.50, 0.375, 0.25). The walking
meta-analysis varied by 1% (RR = 0.89-0.90) and the
cycling by 6% (RR = 0.84-0.90) under these transforma-
tions. These data are shown in Table 2.
Heterogeneity in study results was assessed through
examination of the forest plots and quantified using the
I2 statistic to determine whether the observed variation
in the study results was compatible with the variation
expected by chance alone [12]. We used a random-
effects model as the default to incorporate heterogeneity
between studies. I2 for walking was 82.6% (P < 0.05) and
for cycling was 20.5% (p = 0.27) suggesting considerable
heterogeneity.
We plotted trial effect against standard error and pre-
sented it as a funnel plot (Additional file 4: Figure S2).
Asymmetry could be caused by a relationship between
effect size and sample size or by publication bias, and
we also examined any observed effect for heterogeneity
[34]. We found no evidence of publication bias.
The study by Bath et al. [20] was a considerable outlier
on the forest and funnel plots. By a substantial amount,
this study had the greatest risk reduction at 11.25 MET.
hours per week (0.40 (95% CI = 0.34 to 0.48); see
Table 2). Repeating the analysis with Bath excluded did
not change the pooled estimate for walking.
Dose–response relationship
The incremental change in risk for each MET.hour per
week increase in either walking or cycling for the different
Figure 2 Risk reduction for all cause mortality for an additional 11.25 MET. hours per week of walking (studies displayed by quality score).
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exposure intervals are displayed in Table 3. We found that
the greatest rate of reduction is in the first category for
both behaviours corresponding to 1–120 minutes per
week of walking and 1–101 minutes per week of cycling.
Figures 4 and 5 show these same data as dose–re-
sponse plots for walking and cycling across the ranges of
reported exposures. Walking shows a slowing of the rate
of benefit after 8 MET.hours per week (equivalent to
120 minutes per week at an intensity of 4.0 METs). The
rate may increase slightly after 22.5 MET.hours per
week, but the large confidence interval on the final data
point suggests large uncertainty. The dose–response re-
lationship for cycling shows the rate of received benefits
drops in each subsequent category.
Discussion
The meta-analyses found an inverse association between
both walking and cycling and risk of ACM. Including
the most studies and person years, this is the largest
walking meta-analysis and the first cycling meta-analysis
to estimate the effect on ACM, adjusted for other phys-
ical activity. The results suggest that groups reporting an
additional 11.25 MET.hours per week of walking (com-
pared to groups reporting none or very little) reduce the
risk of ACM by 11%. For cycling the risk-reduction is
10%. We tested the sensitivity of our analysis at 11.25
MET.hours per week to various dose–response relation-
ships. The results were found to be robust at this expos-
ure, particularly for walking.
We also investigated the shape of the dose–response
relationship across the entire range of exposures (i.e. not
limited to 11.25 MET.hours per week). Our analysis of
these relationships suggested the largest effects in the
first exposure category with decreasing rates of benefi-
cial effects as the exposure to walking or cycling
increased.
Strengths and limitations
The estimates for walking are based on 280000 partici-
pants and 2.6 million person-years and for cycling they
are based on 187000 individuals and 2.1 million person-
years. Further, the included studies were all high quality
as assessed by the Newcastle-Ottawa scale. We only
included studies that controlled for other domains of
PA. This means the risk reductions calculated are more
likely to be the result of walking or cycling exposure,
independent of a confounding effect of other PA. How-
ever, the different ways and extents to which the studies
Figure 3 Risk reduction for all cause mortality for an additional 11.25 MET. hours per week of cycling (studies displayed by quality score).
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assessed other PA prior to adjustment is a limitation to
this method. The broad range of reported exposures also
allowed us to investigate the dose–response relationships
for walking and cycling across the distributions typically
observed in general populations.
Included studies were predominantly from developed
countries. It is not clear how generalizable the results
would be to low and middle income countries where
environmental or social factors might be different (e.g.
road safety, air pollution, or prevalence of PA from
other sources). While there was no evidence of publica-
tion bias in the funnel plots, we cannot completely rule
out this possibility. Many studies were from large
cohorts not specifically designed to test walking or
cycling; it is possible other similar cohort studies finding
non-significant or non-beneficial results did not publish
their findings. The I2 statistic suggested considerable
heterogeneity, especially for walking. This could be due
to differences in exposure categorisation or sample bias,
or due to residual confounding. The Bath study was a
considerable outlier. It also had the one of the crudest
categorisations of walking exposure (more or less than
10 minutes per day) which led to a large risk reduction
when extrapolated to 11.25 MET.hours per week.
To convert the exposures to the same metric we had
to make certain assumptions about intensity of behav-
iours and width of category ranges. These assumptions
are needed as epidemiological studies on walking and
cycling and ACM rarely capture distributions of speeds
and intensities [19,31]. The intensity assumptions were
reasonable and transparent; they are based on the widely
used Compendium of Activities and the assumptions
about mid-points of open ended ranges were necessary
for our chosen approach. The results were shown to be
robust to intensity selections. However, we must
acknowledge that while required for our method, these
assumptions and conversions may introduce some
error. Further, at a population level walking and cycling
will be described by a wide range of intensities based
on individual fitness, journey purpose and terrain. For
the meta-analysis of pooled relative risks, the choice of
exposure categories is to some extent subjective and
this is a known limitation of this approach.
The conversion of exposures to MET.hours per week
and calculation of point estimates for risk is justified as
this approach quantifies the exposure required for a
given effect. This allows the reader to consider how
much walking or cycling is required for a given effect
and is a strength of our study.
As with many epidemiological studies, the measures
of walking and cycling were often varied and crudely
defined. In all cases they were self-reported. Our
assumptions are unlikely to have added substantial
further uncertainty; the exposure data allow us to esti-
mate broad exposure to walking or cycling and the
assumptions do not detract from this ability. Recent
studies have also suggested that self-reported walking
and cycling may be relatively valid at the group level
[35]. We are confident that the findings are robust with
regards to the methodological parameters available and
selected for this analysis. The consistency of results
across the studies, despite using different exposure
levels and taking place in different walking and cycling
environments support the overall conclusion of a bene-
ficial effect of these forms of physical activity.
Comparison to previous literature
For walking a previous meta-analysis found a relative risk
for ACM of 0.68 (95% CI = 0.59 to 0.78) [5]. However this
study did not specify or treat exposure in quantitative
terms and thus it is not known how much walking confers
this benefit. A meta-analysis of 13 studies by Samitz et al.,
reported a smaller reduced risk of 0.97 (95% CI = 0.95 to
0.99) for an increment one hour per week of walking [2].
Table 2 Meta-analysis results for different
transformations simulating dose–response relationships
Walking Cycling
Dose–response Relative risk 95% CI Relative risk 95% CI
Linear 0.89 0.83-0.96 0.90 0.87-0.94
Log-linear 0.90 0.85-0.95 0.90 0.86-0.94
0.75 power 0.90 0.85-0.95 0.89 0.85-0.93
0.50 power 0.90 0.86-0.94 0.87 0.83-0.91
0.375 power 0.90 0.86-0.94 0.86 0.81-0.91
0.25 power 0.90 0.86-0.94 0.84 0.79-0.90
Relative risks and 95% confidence interval estimated at 11.25 MET. hours
per week.
Table 3 Incremental change in relative risk for 1 MET. hour per week increase in walking or cycling
Walking Cycling
Exposure
category
Exposure range
in MET. hours
per week
Exposure range in
minutes per week
(@ 4.0 METs)
Change in relative risk
for 1 MET. hour per
week increase (x103)
Exposure range
in MET. hours
per week
Exposure range in
minutes per week
(@ 6.8 METs)
Change in relative risk
for 1 MET. hour per
week increase (x103)
Category 1 0.1 to 8.0 1-120 13.75 0.1 to 11.5 1-101 14.78
Category 2 8.0 to 22.5 120-338 2.07 11.5 to 32.0 101-282 3.41
Category 3 22.5 to 50.0 338-750 2.91 32.0 to 65.0 282-574 1.82
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This is a lower exposure than we have used to calculate
our risk reduction; extrapolated to our exposure this risk
would be 0.92 which is 27% smaller than the magnitude of
our finding. Neither analysis considered whether included
studies had controlled for other PA.
A more recent meta-analysis of walking fitted a 0.375
power transformation to the exposure and standardised
at 11 MET.hours per week. The authors reported a rela-
tive risk of 0.89 (95% CI = 0.82 to 0.96) however they
were only able to include five cohort studies (1.6 million
person years) in this analysis [3]. They also included
one study in which the exposure was a combination of
walking and standing time [36]. Our results confirm this
finding in a more robust analysis with new studies,
more studies (all graded high quality) and covering 2.6
million person years.
A meta-analysis of cycling has not previously been
possible due to the low number of published studies
though Oja et al., and Saunders et al., have previously
reviewed benefits for reduced morbidity from cycling
[4,8]. This meta-analysis is helpful as individual studies
have reported relative risks as low as 0.44 (95% CI = 0.40
to 1.07) [31] and as high as 1.02 (95% CI = 0.77 to 1.35)
[32]. A meta-analysis of leisure-time physical activity
(which might be considered similar to cycling) by Samitz
et al., reported a risk reduction of 0.94 (95% CI = 0.92-
Figure 5 Dose-response relationship for cycling across the range of reported exposures.
Figure 4 Dose-response relationship for walking across the range of reported exposures.
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0.97) for an increment one hour of physical activity per
week [2]. This analysis was based on seven studies, which
did not all adjust for other PA. Extrapolated to our expos-
ure this risk would be 0.90 which agrees with our finding.
It is now widely theorized that there is a non-linear
dose–response relationship between various physical
activities and reduced risk for all-cause mortality [3].
Woodcock presented a 0.375 power transform for
walking and a 0.25 transform for non-vigorous PA. Oja
et al. found evidence of an inverse step-wise decrease
and a “ceiling effect” for general health benefit through
increased cycling [4]. We chose to analyse the possible
non-linear dose–response relationship through meta-
analysis of pooled relative risks within three exposure
intervals. This allowed us to better reflect the reported
physiological effects at low and high exposures and the
non-linear nature of the relationship between walking
or cycling and ACM across the broad range of expo-
sures. Another approach for modelling the quantitative
exposure-response relationship is the use of cubic
splines [37,38] but many of our studies had dichotom-
ous exposure variables, meaning they could not be
included in such analysis and precluding this more ad-
vanced tool [37].
Implications
Previous walking analyses presented researchers with a
wide range (3 to 32%) of possible risk reductions. With our
results, researchers can now model effects of walking and
cycling, and compare to other risk factors, with greater
confidence. Previous cycling modelling had to rely on
results from single studies [39] and this new analysis will
provide a better (and more conservative) estimate for
researchers and modellers. We also present dose–response
relationships for considering benefits across walking and
cycling activity levels when before and after data are avail-
able to model change from different baseline exposures.
Combined the results presented in this paper will provide a
stronger information base for health impact assessment,
economic analysis and active travel policy.
These results confirm that public health policy and
recommendations should include walking and cycling.
Walking in particular is an important behaviour as it is
free, accessible and requires no equipment or training;
it has been described as the nearest thing to “perfect
exercise” [40]. Walking and cycling promotion strat-
egies should also consider safety aspects to ensure that
the positive health effects are not diminished by acci-
dents in these more vulnerable road users [41]. The
dose–response results suggest the greatest impact is in
the first exposure category of walking and cycling per
week. This is the first 120 minutes per week for walking
and the first 100 minutes per week for cycling. Public
health population approaches to PA promotion should
focus on promotion and maintenance in this range for
the greatest impact on ACM.
It may be considered unexpected that cycling, trad-
itionally a more intense activity than walking had a very
similar risk reduction (1 percentage point difference).
We note that this is for the same energy expenditure,
but as cycling is more intense, would be achieved in a
shorter time (100 minutes per week for cycling; 170 -
minutes per week for walking).
Our methods have demonstrated a robust way to com-
bine multiple studies with heterogeneous exposures in
meta-analysis and estimate (1) the effect at PA recommen-
dations and (2) the dose–response across the exposure
range. Our paper also shows the need for improvement in
exposure assessment. We have provided outputs that will
be suitable for simple and complex modelling such as the
Integrated Transport and Health Impact Modelling Tool
(ITHIM) [42], the Health Economic Assessment Tool
(HEAT) for walking and cycling [39,43] or integrated
models for preventable risk [44]. We have confirmed the
beneficial effects and the greater importance of increasing
the behaviours at low levels.
Future research
Systematic reviews generally report the need to update
their results once new studies are published. We reserve
judgement on this; the advent of cohort studies using
objective exposure assessments such as accelerometer,
pedometer or GPS (global positioning system) devices
may indicate that subsequent reviews start afresh if ex-
posures are non-comparable.
As more evidence does become available we recom-
mend investigation of benefits and dose–response pat-
terns by age, gender and geographic region. It is also
important that studies of walking and cycling are con-
ducted in low- and middle-income settings and included
in any future iterations of this review to make the global
utility of the findings more robust.
Conclusions
Walking and cycling confer 11% and 10% reductions in
risk of ACM in groups that conduct 11.25 MET.hours
per week. This effect is after adjustment for other PA.
Analysis of dose–response suggests decreasing rate of
benefit at higher exposures.
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